Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/126526
Full metadata record
DC FieldValueLanguage
dc.creatorSpencer, AP-
dc.creatorTorrado, M-
dc.creatorCustódio, B-
dc.creatorSilva-Reis, SC-
dc.creatorSantos, S-
dc.creatorLeiro, V-
dc.creatorPêgo, AP-
dc.date.accessioned2020-03-03T16:59:48Z-
dc.date.available2020-03-03T16:59:48Z-
dc.date.issued2020-02-23-
dc.identifier.issn1999-4923-
dc.identifier.urihttps://hdl.handle.net/10216/126526-
dc.description.abstractCentral nervous system (CNS) disorders encompass a vast spectrum of pathological conditions and represent a growing concern worldwide. Despite the high social and clinical interest in trying to solve these pathologies, there are many challenges to bridge in order to achieve an effective therapy. One of the main obstacles to advancements in this field that has hampered many of the therapeutic strategies proposed to date is the presence of the CNS barriers that restrict the access to the brain. However, adequate brain biodistribution and neuronal cells specific accumulation in the targeted site also represent major hurdles to the attainment of a successful CNS treatment. Over the last few years, nanotechnology has taken a step forward towards the development of therapeutics in neurologic diseases and different approaches have been developed to surpass these obstacles. The versatility of the designed nanocarriers in terms of physical and chemical properties, and the possibility to functionalize them with specific moieties, have resulted in improved neurotargeted delivery profiles. With the concomitant progress in biology research, many of these strategies have been inspired by nature and have taken advantage of physiological processes to achieve brain delivery. Here, the different nanosystems and targeting moieties used to achieve a neuronal delivery reported in the open literature are comprehensively reviewed and critically discussed, with emphasis on the most recent bioinspired advances in the field. Finally, we express our view on the paramount challenges in targeted neuronal delivery that need to be overcome for these promising therapeutics to move from the bench to the bedside.pt_PT
dc.description.sponsorshipThis work was financially supported by the project PTDC/CTM-NAN/3547/2014 (POCI-01-0145-FEDER-016639) funded by FEDER funds through the Programa Operacional Competitividade e Internacionalização-COMPETE 2020 and Portuguese funds through FCT–Fundação para a Ciência e a Tecnologia. A.P.S., B.C. and S.D.S. acknowledge FCT for the Ph.D. scholarships (SFRH/BD/137073/2018 and SFRH/BD/145652/2019) and the contract under the Norma Transitória–DL57/2016/CP/CP1360/CT0013, respectively. V.L. acknowledges her contract in the framework of the project NORTE-01-0247-FEDER-033399, funded by FEDER funds through the Sistema de Incentivos à Investigação e Desenvolvimento Tecnológico (SI I&DT), Aviso nº 03/SI/2017, Projetos em Co-promoção do Programa Interfacept_PT
dc.language.isoengpt_PT
dc.publisherMDPIpt_PT
dc.relation.ispartofseriesPharmaceutics, vol. 12(2), p. E192pt_PT
dc.rightsopenAccesspt_PT
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectCNS disorderspt_PT
dc.subjectBioinspiredpt_PT
dc.subjectDrug deliverypt_PT
dc.subjectNanocarrierspt_PT
dc.subjectNanomedicinept_PT
dc.subjectNeurotargetingpt_PT
dc.titleBreaking Barriers: Bioinspired Strategies for Targeted Neuronal Delivery to the Central Nervous Systempt_PT
dc.typeArtigo em Revista Científica Internacionalpt_PT
dc.contributor.uportoInstituto de Investigação e Inovação em Saúdept_PT
dc.identifier.doi10.3390/pharmaceutics12020192-
dc.relation.publisherversionhttps://www.mdpi.com/1999-4923/12/2/192-
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.3390-pharmaceutics12020192.pdf1.67 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons